Crohn's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Crohn's Disease, including details on symptoms, diagnosis, treatment, causes, medication.

Volume 3 (2006), Issue 7 (July)

1. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
   Am J Surg Pathol, 30(7): 871-7. [Abstract] [Full-text]
2. Clinical features affecting final adult height in patients with pediatric-onset Crohn's disease.
   Pediatrics, 118(1): 124-9. [Abstract] [Full-text]
3. Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?
   Gastroenterology, 131(1): 85-96. [Abstract] [Full-text]
4. Comparison of laparoscopic and open ileocecal resection for Crohn's disease: a metaanalysis.
   Surg Endosc, 20(7): 1036-44. [Abstract] [Full-text]
5. Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease.
   Gut, 55(8): 1131-7. [Abstract] [Full-text]
6. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease.
   Gut, 55(8): 1138-44. [Abstract] [Full-text]
7. Phenotype at diagnosis predicts recurrence rates in Crohn's disease.
   Gut, 55(8): 1124-30. [Abstract] [Full-text]
8. Concurrent development of Crohn disease and myelodysplastic syndrome in a child: case report and literature review.
   Pediatr Hematol Oncol, 23(6): 477-83. [Abstract] [Full-text]
9. MR Enteroclysis of inflammatory small-bowel diseases.
   AJR Am J Roentgenol, 187(2): 522-31. [Abstract] [Full-text]
10. Genetic variants and the risk of Crohn's disease: what does it mean for future disease management?
    Expert Opin Pharmacother, 7(12): 1591-602. [Abstract] [Full-text]

© 2004-2008 Crohn's Disease Research Today. All Rights Reserved.